血清DLL4、VASH-1、CTRP9水平与视网膜静脉阻塞患者继发黄斑水肿的关系及对预后的影响OA
The relationship between serum DLL4,VASH-1,CTRP9 levels with secondary macular edema in patients with retinal vein occlusion and their impact on prognosis
目的 探究血清Delta样配体4(DLL4)、血管生成抑制蛋白-1(VASH-1)、C1q肿瘤坏死因子相关蛋白9(CTRP9)水平与视网膜静脉阻塞(RVO)患者继发黄斑水肿的关系及对预后的影响.方法 前瞻性病例对照研究.选取本院2023年3月至2024年11月收治的109例RVO继发黄斑水肿患者作为黄斑水肿组,根据黄斑水肿程度分为轻度水肿组(n=48)、中度水肿组(n=35)和重度水肿组(n=26).另选同期本院收治的109例单纯RVO患者为单纯RVO组,进行体检的109例体检健康者为健康对照组.采用酶联免疫吸附试验检测血清DLL4、VASH-1、CTRP9水平.根据患者治疗3个月后视力恢复情况将黄斑水肿组分为预后良好组和预后不良组.绘制受试者工作特征(ROC)曲线分析血清DLL4、VASH-1、CTRP9预测RVO患者继发黄斑水肿预后的效能;采用多因素Logistic回归分析RVO患者继发黄斑水肿预后影响因素.结果 健康对照组、单纯RVO组、黄斑水肿组血清DLL4、VASH-1水平依次升高,CTRP9水平依次降低(均P<0.05).轻度水肿组、中度水肿组、重度水肿组血清DLL4、VASH-1水平依次升高,CTRP9水平依次降低(均P<0.05).预后不良组舒张压、血清DLL4、VASH-1水平高于预后良好组,CTRP9水平低于预后良好组(均P<0.05).血清DLL4、VASH-1、CTRP9单独及三者联合预测RVO患者继发黄斑水肿预后的曲线下面积(AUC)分别为 0.834,0.845,0.841,0.949,联合预测的 AUC 高于 DLL4、VASH-1、CTRP9 单独预测(Z=3.423,4.490,4.374,均P<0.05).多因素Logistic回归分析,结果显示,血清DLL4、VASH-1、CTRP9水平是RV0患者继发黄斑水肿预后的影响因素(均P<0.05).结论 RVO继发黄斑水肿患者血清DLL4、VASH-1水平升高,CTRP9水平降低,可作为预测RVO患者继发黄斑水肿预后的潜在生物指标.
Objective To discuss the relationship between serum Delta like ligand 4(DLL4),vasohibin-1(VASH-1),C1q tumor necrosis factor related protein 9(CTRP9)and secondary macular edema in patients with retinal vein occlusion,and their impact on prognosis.Methods A prospective case-control study.109 patients with retinal vein occlu-sion and secondary macular edema who were admitted to our hospital from March 2023 to November 2024 were included as the macular edema group.Complying with the degree of macular edema,they were assigned into the mild edema group(na=48),the moderate edema group(n=35),and the severe edema group(n=26).Another 109 patients with simple retinal vein occlusion in our hospital were served as the retinal vein occlusion group,and 109 healthy individuals who underwent physi-cal check ups were served as the healthy control group.Enzyme linked immunosorbent assay was used to detect serum DLL4,VASH-1,and CTRP9.Complying with the visual recovery of patients after three months of treatment,the macular edema group was classified into the good prognosis group and the poor prognosis group.The receiver operating characteris-tic(ROC)curve was plotted to analyze the efficacy of serum DLL4,VASH-1,and CTRP9 in predicting the prognosis of pa-tients with retinal vein occlusion and secondary macular edema.Multivariate Logistic regression was used to analyze the prognostic factors of secondary macular edema in patients with retinal vein occlusion.Results Serum DLL4 and VASH-1 increased sequentially in the healthy control group,retinal vein occlusion group,and macular edema group,while CTRP9 decreased sequentially(all P<0.05).Serum DLL4 and VASH-1 increased sequentially in the mild edema group,the moder-ate edema groupand the severe edema group,while CTRP9 decreased sequentially(all P<0.05).The poor prognosis group had higher diastolic blood pressure,serum DLL4,and VASH-1,and lower CTRP9 than the good prognosis group(all P<0.05).The area under the curve(AUC)values for predicting the prognosis of patients with retinal vein occlusion and second-ary macular edema using serum DLL4,VASH-1,and CTRP9 separately or their joint were 0.834,0.845,0.841,and 0.949,re-spectively,the AUC predicted by their joint was higher than that separate predictions(Z=3.423,4.490,4.374,all P<0.05).Multivariate logistic regression analysis showed that serum DLL4,VASH-1,and CTRP9 were influencing factors for the prognosis of patients with retinal vein occlusion and secondary macular edema(all P<0.05).Conclusions Serum DLL4 and VASH-1 are elevated,and CTRP9 is decreased in patients with retinal vein occlusion and secondary macular edema,and they can serve as potential biological indicators for predicting the prognosis of patients with retinal vein occlusion and secondary macular edema.
翟晓羽;宗志峰;李俊枝;要青清;侯林静;王红燕;姜璐璐
056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院056004 河北邯郸,河北省邯郸市第一医院
视网膜静脉阻塞黄斑水肿Delta样配体4血管生成抑制蛋白-1C1q肿瘤坏死因子相关蛋白9预后
Retinal vein occlusionMacular edemaDelta like ligand 4Vasohibin-1C1q tumor necrosis factor related protein 9Prognosis
《临床眼科杂志》 2026 (4)
297-302,6
评论